We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$80.6B
AUM Growth
-$1.86B
Cap. Flow
-$4.73B
Cap. Flow %
-5.87%
Top 10 Hldgs %
16.72%
Holding
1,832
New
167
Increased
677
Reduced
621
Closed
126

Top Buys

Rank Stock Value
1
CDW icon
CDW
CDW
+$333M
2
CSX icon
CSX Corp
CSX
+$216M
3
SCHW
Charles Schwab
SCHW
+$213M
4
ENB icon
Enbridge
ENB
+$207M
5
APP icon
Applovin
APP
+$195M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Financials 14.68%
3 Healthcare 12.42%
4 Industrials 10.7%
5 Consumer Discretionary 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDN icon
1151
Radian Group
RDN
$5.14B
$2.3M ﹤0.01%
69,500
NCNO icon
1152
nCino
NCNO
$1.81B
$2.29M ﹤0.01%
83,289
-1,926
-2% -$60.9K
VCTR icon
1153
Victory Capital Holdings
VCTR
$6.08B
$2.27M ﹤0.01%
39,300
QSR icon
1154
Restaurant Brands International
QSR
$25.1B
$2.23M ﹤0.01%
+23,238
New +$1.5M
GBCI icon
1155
Glacier Bancorp
GBCI
$6.55B
$2.23M ﹤0.01%
+50,408
New +$2.43M
CVE icon
1156
Cenovus Energy
CVE
$54.6B
$2.22M ﹤0.01%
+111,233
New +$1.6M
ICL icon
1157
ICL Group
ICL
$6.81B
$2.21M ﹤0.01%
+105,899
New +$623K
SNDX icon
1158
Syndax Pharmaceuticals
SNDX
$1.84B
$2.21M ﹤0.01%
180,000
FCN icon
1159
FTI Consulting
FCN
$4.82B
$2.2M ﹤0.01%
13,410
-9,214
-41% -$1.66M
WVE icon
1160
Wave Life Sciences
WVE
$1.12B
$2.2M ﹤0.01%
272,326
+38,645
+17% +$423K
XHR
1161
Xenia Hotels & Resorts
XHR
$1.98B
$2.2M ﹤0.01%
186,909
-1,399
-0.7% -$19.5K
IIPR icon
1162
Innovative Industrial Properties
IIPR
$1.78B
$2.17M ﹤0.01%
40,143
+368
+0.9% +$25.5K
VRDN icon
1163
Viridian Therapeutics
VRDN
$2.13B
$2.17M ﹤0.01%
160,948
+18,555
+13% +$316K
RPRX icon
1164
Royalty Pharma
RPRX
$26.1B
$2.15M ﹤0.01%
69,169
+23,021
+50% +$730K
PRVA icon
1165
Privia Health
PRVA
$3.21B
$2.15M ﹤0.01%
95,783
-2,214
-2% -$51.4K
PHR icon
1166
Phreesia
PHR
$632M
$2.15M ﹤0.01%
84,082
-10,257
-11% -$279K
S icon
1167
SentinelOne
S
$6.22B
$2.14M ﹤0.01%
117,928
-2,727
-2% -$59.2K
CNX icon
1168
CNX Resources
CNX
$4.85B
$2.13M ﹤0.01%
67,800
CWT icon
1169
California Water Service
CWT
$3.04B
$2.13M ﹤0.01%
43,914
-796
-2% -$36.1K
XNCR icon
1170
Xencor
XNCR
$1.44B
$2.13M ﹤0.01%
200,000
VVV icon
1171
Valvoline
VVV
$4.97B
$2.13M ﹤0.01%
61,034
-1,411
-2% -$51.5K
SMMT icon
1172
Summit Therapeutics
SMMT
$10.9B
$2.12M ﹤0.01%
109,713
+23,960
+28% +$481K
MAC icon
1173
Macerich
MAC
$7.32B
$2.11M ﹤0.01%
122,847
+36,989
+43% +$707K
WFG icon
1174
West Fraser Timber
WFG
$5.18B
$2.11M ﹤0.01%
20,051
+16,613
+483% +$1.37M
IWM icon
1175
iShares Russell 2000 ETF
IWM
$79.8B
$2.09M ﹤0.01%
10,493
-5,665
-35% -$1.23M

Similar funds

Macquarie Group's Q1 2025 Portfolio in Review

As of Q1 2025, Macquarie Group held 1,832 positions worth $80.6B, down 2.3% from $82.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Macquarie Group withdrew a net $4.73B in Q1 2025, closing 126 positions and reducing 621 holdings. Its most notable exit was iShares Core US Aggregate Bond ETF, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Macquarie Group opened a new position in Unity worth $77M.

  • Macquarie Group's largest Q1 2025 buy was Unity: 3,930,157 shares worth $77M.
  • Macquarie Group added most to CDW in Q1 2025, an estimated $333M increase.
  • Macquarie Group's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $619M.
  • Macquarie Group fully exited iShares Core US Aggregate Bond ETF in Q1 2025, selling an estimated $160M.
  • Macquarie Group's ten largest holdings make up 17% of its $80.6B portfolio in Q1 2025.
  • Macquarie Group opened 167 new positions and closed 126 in Q1 2025.
  • Macquarie Group's portfolio value fell 2.3% quarter-over-quarter to $80.6B.

Based on Macquarie Group's 13F filing for Q1 2025, filed 15 May 2025.